Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure.


Journal

Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123

Informations de publication

Date de publication:
08 2019
Historique:
received: 21 12 2018
accepted: 15 04 2019
revised: 06 04 2019
pubmed: 19 5 2019
medline: 2 10 2020
entrez: 19 5 2019
Statut: ppublish

Résumé

Between 30 and 60% of HIV-seropositive individuals develop symptoms of clinical depression and/or apathy. Dopamine and serotonin are associated with motivational alterations; however, histamine is less well studied. In the present study, we used fast-scan cyclic voltammetry in HIV-1 transgenic (Tg) rats to simultaneously analyze the kinetics of nucleus accumbens dopamine (DA), prefrontal cortical serotonin (5-HT), and hypothalamic histamine (HA). For voltammetry, subjects were 15 HIV-1 Tg (7 male, 8 female) and 20 F344/N (11 male, 9 female) adult rats. Both serotonergic and dopaminergic release and reuptake kinetics were decreased in HIV-1 Tg animals relative to controls. In contrast, rates of histamine release and reuptake increased in HIV-1 Tg rats. Additionally, we used immunohistochemical (IHC) methods to identify histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus. For IHC, subjects were 9 HIV-1 Tg (5 male, 4 female) and 9 F344/N (5 male, 4 female) adult rats. Although the total number of TMN histaminergic cells did not differ between HIV-1 Tg rats and F344/N controls, a significant sex effect was found, with females having an increased number of histaminergic neurons, relative to males. Collectively, these findings illustrate neurochemical alterations that potentially underlie or exacerbate the pathogenesis of clinical depression and/or apathy in HIV-1.

Identifiants

pubmed: 31102184
doi: 10.1007/s13365-019-00754-x
pii: 10.1007/s13365-019-00754-x
pmc: PMC6750960
mid: NIHMS1529603
doi:

Substances chimiques

Viral Proteins 0
Serotonin 333DO1RDJY
Histamine 820484N8I3
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

540-550

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH106563
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM081740
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH109959
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100624
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA013137
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106392
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD043680
Pays : United States

Références

Pharmacol Biochem Behav. 1999 Nov;64(3):605-10
pubmed: 10548278
J Psychopharmacol. 2000;14(3):222-7
pubmed: 11106300
Prog Neurobiol. 2001 Apr;63(6):637-72
pubmed: 11164999
Neuropsychopharmacology. 2001 Apr;24(4):399-409
pubmed: 11182535
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9271-6
pubmed: 11481487
Neuron. 2002 Mar 28;34(1):13-25
pubmed: 11931738
Nat Rev Neurosci. 2003 Feb;4(2):121-30
pubmed: 12563283
J Neurosci. 2004 Oct 6;24(40):8704-10
pubmed: 15470136
J Neurosci. 2004 Oct 27;24(43):9531-40
pubmed: 15509740
J Neurovirol. 2006 Apr;12(2):140-5
pubmed: 16798675
Trends Neurosci. 1991 Sep;14(9):415-8
pubmed: 1720584
J Neurosci. 2007 Jul 25;27(30):8138-48
pubmed: 17652604
Hippocampus. 2008;18(2):135-47
pubmed: 17924522
Neurosci Biobehav Rev. 2008 Jul;32(5):883-909
pubmed: 18430470
Toxicol Pathol. 2008 Apr;36(3):375-84
pubmed: 18441260
Neuroimage. 2008 Aug 15;42(2):869-78
pubmed: 18579413
Neurotoxicology. 2008 Nov;29(6):971-7
pubmed: 18606182
Synapse. 2009 Mar;63(3):181-5
pubmed: 19086089
J Pharmacol Exp Ther. 2009 Jun;329(3):1071-83
pubmed: 19325033
Neuroscience. 2009 Apr 10;159(4):1292-9
pubmed: 19344635
Anal Chem. 2009 Nov 15;81(22):9462-71
pubmed: 19827792
J Neurovirol. 2011 Feb;17(1):26-40
pubmed: 21165787
Ann N Y Acad Sci. 2011 Jan;1216:86-98
pubmed: 21272013
Mol Neurobiol. 2011 Aug;44(1):102-10
pubmed: 21717292
J Nerv Ment Dis. 2012 Apr;200(4):336-42
pubmed: 22456588
J Neuroimmune Pharmacol. 2012 Sep;7(3):629-39
pubmed: 22570010
Front Syst Neurosci. 2012 May 04;6:33
pubmed: 22586376
Arch Clin Neuropsychol. 2012 Aug;27(5):520-31
pubmed: 22705481
Front Syst Neurosci. 2012 Jul 04;6:51
pubmed: 22783171
Neuroscience. 1990;34(1):127-32
pubmed: 2325846
Exp Neurol. 2013 Oct;248:228-35
pubmed: 23811015
Psychiatry Res. 2014 Jan 30;215(1):208-16
pubmed: 24290100
J Neuroimmune Pharmacol. 2014 Dec;9(5):642-53
pubmed: 25037595
J Clin Diagn Res. 2014 Oct;8(10):WC01-4
pubmed: 25478433
AIDS Behav. 2015 Aug;19(8):1430-7
pubmed: 25533921
Curr HIV Res. 2015;13(1):21-42
pubmed: 25613135
J Comp Neurol. 1989 Mar 8;281(2):169-92
pubmed: 2565348
Brain Behav Immun. 2015 Aug;48:336-49
pubmed: 25733103
Analyst. 2015 Jun 7;140(11):3759-65
pubmed: 25902865
Neurosci Biobehav Rev. 2015 Aug;55:147-64
pubmed: 25944459
J Neurovirol. 2016 Jun;22(3):282-92
pubmed: 26501780
PLoS One. 2016 Feb 01;11(2):e0147182
pubmed: 26829391
Addict Biol. 2016 Sep;21(5):1052-9
pubmed: 26935336
J Neurochem. 2016 Aug;138(3):374-83
pubmed: 27167463
Front Psychiatry. 2016 Jun 20;7:102
pubmed: 27378953
Sci Rep. 2016 Sep 06;6:32831
pubmed: 27596023
Dialogues Clin Neurosci. 2016 Dec;18(4):395-402
pubmed: 28179811
J Comp Neurol. 1987 Sep 1;263(1):1-24
pubmed: 2822770
J Neurovirol. 2018 Apr;24(2):229-245
pubmed: 28730408
Nucl Med Biol. 2017 Dec;55:27-33
pubmed: 29031113
Front Behav Neurosci. 2017 Nov 06;11:212
pubmed: 29163084
PLoS One. 2017 Nov 27;12(11):e0188404
pubmed: 29176843
Cochrane Database Syst Rev. 2018 Jan 22;1:CD008525
pubmed: 29355886
Sci Rep. 2018 May 18;8(1):7869
pubmed: 29777165
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):101-107
pubmed: 29847476
Front Behav Neurosci. 2018 Nov 22;12:285
pubmed: 30524255
Sci Rep. 2019 Jan 29;9(1):827
pubmed: 30696863
Neurosci Lett. 1983 Sep 9;39(3):249-54
pubmed: 6355911
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6
pubmed: 6371818
Clin Chem. 1994 Feb;40(2):288-95
pubmed: 7508830
J Affect Disord. 1993 Jun;28(2):117-24
pubmed: 8354767
J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):320-9
pubmed: 9706540

Auteurs

Adam R Denton (AR)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA.

Srimal A Samaranayake (SA)

Department of Chemistry, University of South Carolina, Columbia, SC, USA.

Kristin N Kirchner (KN)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA.

Robert F Roscoe (RF)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA.

Shane N Berger (SN)

Department of Chemistry, University of South Carolina, Columbia, SC, USA.

Steven B Harrod (SB)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA.

Charles F Mactutus (CF)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA.

Parastoo Hashemi (P)

Department of Chemistry, University of South Carolina, Columbia, SC, USA.

Rosemarie M Booze (RM)

Behavioral Neuroscience Laboratory, Department of Psychology, University of South Carolina, Columbia, SC, USA. booze@mailbox.sc.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH